Iterative Health
Aditya Khosla is an accomplished technology executive and innovator in the field of artificial intelligence and pathology. Currently serving as the CTO and Board Member at Iterative Health since June 2022, Aditya also contributes as an Advisor and Co-founder at PathAI, which focuses on enhancing patient outcomes through AI-driven diagnostic solutions for diseases including cancer. Aditya’s extensive background includes a research assistantship at MIT from September 2011 to September 2016, and research internships at prominent companies such as Microsoft, eBay, and Oracle. Aditya holds a PhD in Computer Science from the Massachusetts Institute of Technology, a Master's degree from Stanford University, and a Bachelor's degree from Caltech, reflecting a strong foundation in computer science, electrical engineering, and economics.
This person is not in any teams
This person is not in any offices
Iterative Health
1 followers
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.
Employees
51-200